Close icon

Spring 2015 Ambulatory and Post-Acute Care Section Bulletin

Featured Buzz | Jan. 22, 2024

By Debbie Bunch January 22, 2024 Gabapentinoids Associated with Severe COPD Exacerbations A population-based study published by the Annals of Internal Medicine suggests COPD patients who take gabapentinoid drugs such as gabapentin and pregabalin are at increased risk for severe COPD exacerbations. In the study, which involved more than 10,000 people with COPD, researchers from … Continued

Respiratory Care Currents

First Biologic for COPD Crosses Another Hurdle According to Sanofi, the biologic drug Dupixent® reduced COPD exacerbations by 34% when compared to placebo in the second of two Phase 3 trials. The NOTUS trial also confirmed that treatment with Dupixent led to rapid and significant improvements in lung function by 12 weeks and that those … Continued

Respiratory Care Currents

COPD Prevalence Remains Flat A study published in the CDC’s Morbidity and Mortality Weekly Report suggests COPD prevalence may have reached a plateau. The investigators arrived at that conclusion after looking at data from the Behavioral Risk Factor Surveillance System, which the CDC defines as “an annual state-based, random-digit-dialed mobile and landline telephone survey among noninstitutionalized U.S. … Continued

AARC Congress 2023 Wrap Up!

The Gaylord Opryland in Nashville, TN, was flooded with respiratory professionals last week, as the AARC hosted its International Respiratory Congress. Attendees came for the continuing education and got the chance to take advantage of unparalleled networking opportunities created by the collegial atmosphere and thousands of clinicians who gathered for the event as well. With … Continued